Journal article
Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
- Abstract:
-
UNLABELLED: Bisphosphonates can increase bone mineral density (BMD) in children with osteogenesis imperfecta (OI). In this study of adults with OI type I, risedronate increased BMD at lumbar spine (but not total hip) and decreased bone turnover. However, the fracture rate in these patients remained high. INTRODUCTION: Intravenous bisphosphonates given to children with OI can increase BMD and reduce fracture incidence. Oral and/or intravenous bisphosphonates may have similar effects in adults...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
- Volume:
- 23
- Issue:
- 1
- Pages:
- 285-294
- Publication date:
- 2012-01-01
- DOI:
- EISSN:
-
1433-2965
- ISSN:
-
0937-941X
- Source identifiers:
-
246069
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:246069
- UUID:
-
uuid:48c9dd9c-ab17-4e8e-b091-06dfda3d3883
- Local pid:
- pubs:246069
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2012
If you are the owner of this record, you can report an update to it here: Report update to this record